Neumann Mark

Neumann Mark is listed in filings as EVP at Intra-Cellular Therapies Inc. (ITCI). This profile follows SEC Form 4 activity through Apr 2, 2025, including sale activity. Recent filings connect the profile to Intra-Cellular Therapies Inc. (ITCI) (ITCI). The current snapshot covers public activity from Aug 20, 2024 to Apr 2, 2025. Reported amounts are shown as $7.0M to $408.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.